Dr. Darling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 Jones Bridge Rd
Uniformed Services University
Bethesda, MD 20814Phone+1 301-295-3528Fax+1 301-295-3150
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1994 - 1999
Duke University HospitalResidency, Dermatology, 1991 - 1994
University of North Carolina HospitalsInternship, Internal Medicine, 1990 - 1991
Duke University School of MedicineClass of 1990
Certifications & Licensure
NC State Medical License 1993 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 2 citationsDiagnosis of Mosaic Tuberous Sclerosis Complex Using Next-Generation Sequencing of Subtle or Unusual Cutaneous Findings.Alison M Treichel, Barbara Boeszoermenyi, Chyi-Chia Richard Lee, Joel Moss, David J Kwiatkowski
JID Innovations. 2023-03-01 - 1 citationsLate-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.Emily W Modlin, Anne M Slavotinek, Thomas N Darling, Stanley Lipkowitz, Frederic G Barr
American Journal of Medical Genetics. Part A. 2022-09-01 - 5 citationsUltrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex.Katarzyna Klonowska, Joannes M Grevelink, Krinio Giannikou, Barbara A Ogorek, Zachary T Herbert
The Journal of Clinical Investigation. 2022-05-16
Journal Articles
- Safety and Efficacy of Low-Dose Sirolimus in the PIK3CA-Related Overgrowth SpectrumThomas N Darling, Brigitte C Widemann, Kristina I Rother, Nature
Press Mentions
USU Researchers Use Therapeutic Peptides to Develop Skin Substitutes for Wound HealingJanuary 18th, 2023- USU Student’s Dedication Leads to Mission Critical, Lifesaving Blood DrivesJanuary 12th, 2023
- Honoring Black Midwifery, Then and NowFebruary 23rd, 2022
- Join now to see all
Grant Support
- Regulation of Dermal Fibroblasts in Skin Regeneration and HealingNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES2012–Present
- Novel In Vitro And Xenograft Models To Study Treatments For Tuberous SclerosisNational Cancer Institute2006–2007
- Tumorigenesis In Tuberous SclerosisNational Cancer Institute2004–2007
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
